Mereo BioPharma (MREO) EBT (2023 - 2026)
Mereo BioPharma (MREO) posted quarterly EBT of -$6.7 million for Q1 2026, up 47.86% year-over-year from -$4.5 million in Q1 2025, and up 8.6% quarter-over-quarter from -$7.4 million in Q4 2025.
Mereo BioPharma (MREO) EBT (2023 - 2026) Analysis & Trends
Mereo BioPharma (MREO) has reported EBT for 4 consecutive years, with -$6.7 million the latest figure, recorded in Q1 2026.
- In Q1 2026, EBT rose 47.86% year-over-year to -$6.7 million; the TTM figure through Mar 2026 stood at -$35.7 million (up 24.33% YoY), while the FY2025 annual figure was -$41.9 million, up 3.18% from the prior year.
- EBT climbed to -$6.7 million in Q1 2026 per MREO's latest filing, from -$7.4 million in the prior quarter.
- Across five years, EBT topped out at -$1.8 million in Q2 2023 and bottomed at -$15.0 million in Q3 2024.
- Historically, EBT has averaged -$9.4 million across 4 years, with a median of -$9.0 million in 2024.
- Annual changes were most pronounced in 2024 — EBT sank 599.89% — and 2025, when it soared 53.18%.
- Mereo BioPharma's EBT stood at -$9.6 million in 2023, then rose by 26.92% to -$7.0 million in 2024, then slipped by 4.33% to -$7.4 million in 2025, then rose by 8.6% to -$6.7 million in 2026.
- Business Quant data shows MREO's EBT at -$6.7 million in Q1 2026, -$7.4 million in Q4 2025, and -$7.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 1.39 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 1.53 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 541.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -767.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 312.46 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 177.81 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -264.70 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -11.37 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 81.49 Mn |
| 10 | Mereo BioPharma | 47.39 Mn | 47.39 Mn | - | -7.01 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -7.01 Mn |
| Mar 31, 2026 | -6.72 Mn |
| Dec 31, 2025 | -7.35 Mn |
| Sep 30, 2025 | -7.02 Mn |
| Jun 30, 2025 | -14.62 Mn |
| Mar 31, 2025 | -12.89 Mn |
| Dec 31, 2024 | -7.05 Mn |
| Sep 30, 2024 | -15.00 Mn |
| Jun 30, 2024 | -12.26 Mn |
| Mar 31, 2024 | -8.95 Mn |
| Dec 31, 2023 | -9.64 Mn |
| Sep 30, 2023 | -6.53 Mn |
| Jun 30, 2023 | -1.75 Mn |
| Mar 31, 2023 | -12.08 Mn |